Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence

doi:10.12998/wjcc.v10.i31.11226

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4923)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

237

WORD

HTML

3281

Figures (1-4)

576

Sum=4121

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

249

Download

553

Sum=802

Nov 6, 2022 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Cases. Nov 6, 2022; 10(31): 11226-11239
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11226

Full Size Figure Download Figure

Figure 4 Summary of the effects of obesogen and diabetogen on tissues and the relationship of these effects with obesity and diabetes. T2DM: Type 2 diabetes mellitus.

Citation: Kurşunoğlu NE, Sarer Yurekli BP. Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence. World J Clin Cases 2022; 10(31): 11226-11239
URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11226.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11226